Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily F Dunn

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Oncologist|July 8, 2009
The role of Src in solid tumorsDeric L Wheeler, Mari Iida, Emily F Dunn
International Journal of Radiation Oncology, Biology, Physics|July 22, 2009
External beam radiotherapy for colon cancer: patterns of careEmily F Dunn, Kevin R Kozak, John S Moody
Nature Reviews. Clinical Oncology|June 17, 2010
Understanding resistance to EGFR inhibitors-impact on future treatment strategiesDeric L Wheeler, Emily F Dunn, Paul M Harari
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2010
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinomaChunrong Li, Mari Iida, Emily F Dunn, et al.
Advances in Radiation Oncology|December 7, 2020
Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment ShortageEmily F Dunn, Adil Akhtar, Adam Dunn, et al.
Gynecologic Oncology|March 25, 2014
Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancerEmily F Dunn, Heather Geye, Chris S Platta, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Effects of treatment duration during concomitant chemoradiation therapy for cervical cancerNarek Shaverdian, Vinai Gondi, Kathryn L Sklenar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2012
Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysisVinai Gondi, Søren M Bentzen, Kathryn L Sklenar, et al.
Cancer Biology & Therapy|July 5, 2011
Erlotinib is a viable treatment for tumors with acquired resistance to cetuximabToni M Brand, Emily F Dunn, Mari Iida, et al.
Cancer Biology & Therapy|March 12, 2009
Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximabDeric L Wheeler, Mari Iida, Tim J Kruser, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Oncologist|July 8, 2009
The role of Src in solid tumorsDeric L Wheeler, Mari Iida, Emily F Dunn
International Journal of Radiation Oncology, Biology, Physics|July 22, 2009
External beam radiotherapy for colon cancer: patterns of careEmily F Dunn, Kevin R Kozak, John S Moody
Nature Reviews. Clinical Oncology|June 17, 2010
Understanding resistance to EGFR inhibitors-impact on future treatment strategiesDeric L Wheeler, Emily F Dunn, Paul M Harari
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2010
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinomaChunrong Li, Mari Iida, Emily F Dunn, et al.
Advances in Radiation Oncology|December 7, 2020
Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment ShortageEmily F Dunn, Adil Akhtar, Adam Dunn, et al.
Gynecologic Oncology|March 25, 2014
Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancerEmily F Dunn, Heather Geye, Chris S Platta, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Effects of treatment duration during concomitant chemoradiation therapy for cervical cancerNarek Shaverdian, Vinai Gondi, Kathryn L Sklenar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2012
Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysisVinai Gondi, Søren M Bentzen, Kathryn L Sklenar, et al.
Cancer Biology & Therapy|July 5, 2011
Erlotinib is a viable treatment for tumors with acquired resistance to cetuximabToni M Brand, Emily F Dunn, Mari Iida, et al.
Cancer Biology & Therapy|March 12, 2009
Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximabDeric L Wheeler, Mari Iida, Tim J Kruser, et al.
Pageof 2